CD86 and neoplasm: Therefore, the HION@Macs could significantly increase M1‐related CD86, TNF‐α, and iNOS markers and decrease M2‐related CD206 marker, as well as, potent dendritic cells (DCs) maturation and tumor infiltration of CD8+ T cells.